iResearch Atlanta

Decatur, Georgia 30330

1 studies enrolling now · 50 studies all time

What they study most

ADHD, Acute Pain, Adjunctive Treatment of Major Depressive Disorder, Adult Attention Deficit Hyperactivity Disorder, Alzheimer Disease, Alzheimer's Disease, Anxiety, Anxiety Generalized, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder

Studies at this site

• A Study of Buntanetap in Participants With PD — Recruiting now
• A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine — Stopped early
• A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) — Running, not enrolling
• A Study to Test Different Doses of BI 1569912 in People With Depression — Completed
• A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1) — Completed
• A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD — Completed
• A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine — Completed
• A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms — Completed
• A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling
• Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD — Stopped early
• A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder — Stopped early
• Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD — Running, not enrolling
• A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease — Completed
• A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD) — Running, not enrolling
• A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder — Completed
• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed
• A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder — Completed
• A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder — Completed
• Bryostatin Treatment of Moderately Severe Alzheimer's Disease — Completed
• A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder — Completed
• Gan & Lee Insulin Glargine Target Type (1) Evaluating Research — Completed
• Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment — Stopped early
• A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder — Completed
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2) — Completed
• Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
• A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication — Completed
• A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine — Completed
• A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD — Completed
• A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease — Completed
• Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) — Stopped early
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
• Gan & Lee Insulin Glargine Target Type (2) Evaluating Research — Completed
• Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder — Completed
• Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm — Completed
• The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder — Completed
• A Study in Patients With Trichotillomania — Completed
• A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® — Stopped early
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD — Completed
• Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder — Status unconfirmed
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics — Completed
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY) — Completed
• A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation — Completed
• Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials — Completed
• Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia — Completed
• A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease — Completed
• Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease — Completed
• A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) — Completed
• A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy — Completed
• Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety — Completed